AOI Biosciences, Inc.

Two applications of molecular recognition

AOI Biosciences develops NeoSelf antibody tests, including a β2GPI test used in infertility and recurrent pregnancy-loss care. The company reports adoption at more than 300 Japanese medical institutions and expansion into other Asian markets.

Its drug-discovery work with Toshiba uses quantum-inspired optimization to investigate allosteric sites on proteins. These sites offer a way to influence a protein's activity away from its conventional binding location. AOI Biosciences is based in Ibaraki, Osaka.